Uri Yablonka insider trades
Open-market stock purchases and sales by Uri Yablonka, EVP & Chief Business Officer at Brainstorm Cell Therapeutics Inc, from SEC Form 4 filings since Jun 6, 2014.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -71%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 26, 2026 | BCLI Brainstorm Cell Therapeutics Inc | Bought (not open market) | — |
Companies traded
- BCLI Brainstorm Cell Therapeutics Inc: 1 buy, last Feb 26, 2026